Norway· NO-ID_AD60493F-C505-4DF3-AF9E-14F0D892CEF8
Orkambi
A ivacaftor and lumacaftor product containing lumacaftor + ivacaftor, registered in Norway by Vertex Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ivacaftor and lumacaftor is registered in 16 of 19 countries.
Countries holding a registration under ATC R07AX30 (ivacaftor and lumacaftor), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 11 of them publish a price we can compare per daily dose
Ivacaftor and lumacaftor · ATC R07AX30
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Lumacaftor + Ivacaftor
- Manufacturer
- Vertex Pharmaceuticals (Ireland) Limited
- Country
- Norway (NO)
- ATC code
- R07AX30
- ATC class
- Ivacaftor and lumacaftor
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_AD60493F-C505-4DF3-AF9E-14F0D892CEF8
- no_varenummer17326756 x 1NOK 143099.5
- gtin351167127001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ivacaftor and lumacaftor in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesORKAMBIVertex Pharmaceuticals Incorporated
- SwitzerlandOrkambi 100 mg / 125 mg, FilmtablettenVertex Pharmaceuticals (CH) GmbH
- CzechiaORKAMBIVertex Pharmaceuticals (Ireland) Limited, Dublin
- SpainORKAMBI 100 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULAVertex Pharmaceuticals (Ireland) Limited
- FinlandOrkambiVertex Pharmaceuticals (Ireland) Limited
- FranceORKAMBI 100 mg/125 mg, comprimé pelliculéVERTEX PHARMACEUTICALS (IRELAND)
- United KingdomOrkambi 100mg/125mg granules sachetsVertex Pharmaceuticals (Europe) Ltd
- IrelandOrkambi 100 mg/125 mg film-coated tabletsVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Orkambi
- Liechtenstein · Orkambi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef4aad00-b5a0-458f-9ca8-6fa2afa0fabb GET /v1/drugs/ef4aad00-b5a0-458f-9ca8-6fa2afa0fabb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat i dosepose",
"source": "fest",
"status": "A",
"atc_name": "Ivakaftor og lumakaftor",
"merkevare_id": "ID_AD60493F-C505-4DF3-AF9E-14F0D892CEF8",
"name_form_strength": "Orkambi gran 150 mg/188 mg",
"prescription_group": "C"
}See everything about ivacaftor and lumacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.